Abingworth Clinical Co-Development Co-Investment Fund
Managed by Abingworth
Overview
Abingworth Clinical Co-Development Co-Investment Fund is a 2023 clinical co-development vehicle focused on late-stage clinical programs with pharmaceutical and biotechnology partners. It forms part of Abingworth’s clinical co-development platform, which provides asset-based development financing for pivotal-stage programs, including new medicines and approved products being evaluated in additional indications.
Abingworth is a transatlantic life sciences investment manager with offices in major biotechnology hubs in the United States and Europe. Its platform invests across seed and early-stage, development-stage, and clinical co-development strategies. Through its clinical co-development strategy, Abingworth finances pivotal-stage biopharmaceutical programs and can support development planning, clinical operations, and regulatory execution through its affiliated operating capabilities. The strategy focuses on assets approaching or in pivotal trials, including both new molecular entities and approved products being developed for new uses.
Selected investments
- Gilead Sciences — The fund invested in Gilead’s development program for Trodelvy in combination with pembrolizumab for first-line PD-L1-high metastatic non-small cell lung cancer.
- Launch Therapeutics — The fund invested in Launch Therapeutics, an operating company that partners with biopharma companies on funding and development of late-stage clinical assets.
- Pathalys Pharma — The fund invested in Pathalys Pharma, a clinical-stage biopharmaceutical company developing upacicalcet for secondary hyperparathyroidism in patients receiving haemodialysis.
Acquire an interest in Abingworth Clinical Co-Development Co-Investment Fund
You might be able to acquire a position in Abingworth Clinical Co-Development Co-Investment Fund. Sign up to explore available positions.
Gauge buyer interest for Abingworth Clinical Co-Development Co-Investment Fund
Sign up here to anonymously gauge interest in your Abingworth Clinical Co-Development Co-Investment Fund position.
Do you manage this fund? Get in touch to edit the text here.